Engineered tissues could one day do the work of traditional electrical stimulation devices while offering more customizable and biologically friendly solutions.

Researchers are developing an AI tool to evaluate placental photographs that could provide predictions for multiple adverse outcomes, such as infection or sepsis.

In a preclinical study, NIBIB researchers found that bone marrow transplants to treat sickle cell disease early in life may lower risk of stroke into adulthood.

A preclinical study in a mouse model of sickle-cell disease showed that stimulating brain regions with focused ultrasound can reduce pain hypersensitivity.

The low image quality of small, affordable MRI machines have prevented their widespread use. But a boost from AI could close the gap, bringing MRI to more patients.

In an effort to greatly expand accessibility, this compact fluorescence-guided surgery system, evaluated in mice, is crafted from cost-effective and off-the-shelf components.

With the help of some of nature’s best engineers, NIBIB-funded researchers have developed technology to regrow damaged facial nerves.

Releasing a drug selectively in specific locations in the body, including the brain, has been challenging. Researchers at the University of Utah have tackled the problem by designing ultrasound-sensitive nanoparticles that release a drug at the targeted site when activated by focused ultrasound.

NIH has awarded more than $4 million in funds and support services to three diagnostic technology developers as part of RADx ® Tech’s Advanced Platforms for HIV Viral Load Monitoring program.